Artificial Intelligence in Life Science Market: Transforming the Future of Drug Discovery The global Artificial Intelligence in Life Science Market is projected to grow from USD 4.8 billion in 2026 to USD 28.1 billion by 2035, expanding at a strong 21.7% CAGR. AI is rapidly reshaping drug discovery, clinical trials, precision medicine, genomics, diagnostics, and regulatory operations by enabling faster data analysis, smarter decision-making, and more efficient R&D workflows. 📊 Key Market Highlights: • North America holds approximately 43% share in 2026 • Software Platforms lead with nearly 48% share • Drug Discovery & Development accounts for around 37% • Asia-Pacific is projected to grow at 24.8% CAGR • Generative AI & Foundation Models are accelerating adoption 🔗 Explore the complete market analysis: https://dimensionmarketresearch.com/report/artificial-intelligence-in-life-science-market/ #ArtificialIntelligence #LifeSciences #AILifeSciences #DrugDiscovery #GenerativeAI #PharmaAI #Biotechnology #ClinicalTrials #PrecisionMedicine #HealthcareAI #MachineLearning #Genomics #DigitalHealth #Pharmaceuticals #Biotech #HealthcareTechnology #MarketResearch #MarketIntelligence #AIInnovation #DimensionMarketResearch